📰 Andreaf Wainer News
Page 17 - Andreaf Wainer News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Andreaf Wainer. Real-time updates on events, politics, business and more.
April 4, 2024
Abbott Laboratories (NYSE:ABT – Free Report) had its price objective lifted by Citigroup from $126.00 to $128.00 in a research report sent to investors on Wednesday, Benzinga reports. They currently have a buy rating on the healthcare product maker’s stock. A number of other research analysts also recently issued reports on ABT. Wells Fargo & […]
April 4, 2024
UMB Bank n.a. reduced its holdings in Abbott Laboratories (NYSE:ABT – Free Report) by 0.3% in the 4th quarter, according to the company in its most recent filing with the SEC. The firm owned 274,008 shares of the healthcare product maker’s stock after selling 704 shares during the quarter. UMB Bank n.a.’s holdings in Abbott […]
April 4, 2024
UMB Bank n.a. reduced its stake in Abbott Laboratories (NYSE:ABT – Free Report) by 0.3% during the 4th quarter, Holdings Channel reports. The fund owned 274,008 shares of the healthcare product maker’s stock after selling 704 shares during the quarter. UMB Bank n.a.’s holdings in Abbott Laboratories were worth $30,160,000 as of its most recent […]
April 3, 2024
Cahaba Wealth Management Inc. decreased its position in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 4.6% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 4,025 shares of the healthcare product maker’s stock after selling 195 shares during the period. Cahaba Wealth […]
April 3, 2024
Hartford Investment Management Co. cut its holdings in Abbott Laboratories (NYSE:ABT – Free Report) by 1.8% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 116,879 shares of the healthcare product maker’s stock after selling 2,094 shares during the quarter. Hartford […]
April 3, 2024
Panoramic Investment Advisors LLC decreased its position in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 6.9% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 25,442 shares of the healthcare product maker’s stock after selling 1,878 shares during […]
April 3, 2024
Hartford Investment Management Co. lowered its stake in Abbott Laboratories (NYSE:ABT – Free Report) by 1.8% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 116,879 shares of the healthcare product maker’s stock after selling 2,094 shares during the period. Hartford Investment […]
April 3, 2024
Panoramic Investment Advisors LLC cut its stake in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 6.9% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 25,442 shares of the healthcare product maker’s stock after selling 1,878 shares […]
April 3, 2024
North Point Portfolio Managers Corp OH lessened its position in Abbott Laboratories (NYSE:ABT – Free Report) by 0.9% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 104,063 shares of the healthcare product maker’s stock after selling 898 shares during […]
April 3, 2024
Hartford Investment Management Co. cut its holdings in Abbott Laboratories (NYSE:ABT – Free Report) by 1.8% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 116,879 shares of the healthcare product maker’s stock after selling 2,094 shares during the quarter. Hartford […]